Post-Surgical Cognitive Outcomes of Moyamoya Disease: A Systematic Review

Devon L Mitchell1, Nathan A Shlobin1, Melissa A LoPresti1

  • 1Division of Pediatric Neurosurgery, Department of Neurological Surgery, Northwestern University Feinberg School of Medicine, Lurie Children's Hospital, Chicago, Illinois, USA.

World Neurosurgery
|July 28, 2023
PubMed
Abstract

Insights

Revascularization surgery improves cognitive outcomes in pediatric Moyamoya disease (MMD) patients, but many still experience impairment. Factors like sex, age at surgery, and prior stroke influence cognitive results.

Area of Science:

  • Neurology
  • Pediatric Neurosurgery
  • Cognitive Neuroscience

Background:

  • Moyamoya disease (MMD) is a progressive cerebrovascular occlusive disease causing stroke in children.
  • Revascularization surgery is the primary treatment for MMD, but its impact on pediatric cognitive function is not well understood.
  • Existing research primarily focuses on clinical and radiographic outcomes, leaving a gap in knowledge regarding cognitive changes post-intervention.

Purpose of the Study:

  • To systematically review and analyze the postoperative cognitive outcomes in pediatric patients with Moyamoya disease.
  • To identify factors associated with cognitive changes following revascularization surgery in children with MMD.
  • To define the specific effects of revascularization surgery on the cognitive performance of pediatric Moyamoya disease patients.

Main Methods:

  • A systematic literature review was conducted adhering to PRISMA guidelines.
  • Searches were performed across PubMed, Embase, and Scopus databases for relevant studies.
  • Inclusion criteria focused on pediatric patients with MMD undergoing revascularization surgery and reporting cognitive outcomes (qualitative or quantitative).

Main Results:

  • Out of 1091 articles, 12 studies involving 446 patients were included in the analysis.
  • Revascularization surgery was linked to maintained or improved intellectual quotient (IQ) and memory functions.
  • Despite overall improvements, 70% of patients exhibited cognitive impairment, with poor school performance noted. Factors like increased cerebral blood flow, female sex, shorter symptom-to-surgery duration, and surgery after age 7 predicted better outcomes, while prior stroke predicted poorer outcomes.

Conclusions:

  • Pediatric Moyamoya disease patients generally show improved cognitive function after revascularization surgery.
  • A significant subset of children with MMD experience persistent cognitive impairment post-surgery.
  • Individual patient factors and treatment-related variables are crucial for risk stratification and optimizing management strategies in pediatric Moyamoya disease.